Compare Becton Dickinson and Co (BDX) vs Block Inc (XYZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Block Inc — how do they compare? Becton Dickinson and Co trades at $155.79 (market cap $41.51B), while Block Inc trades at $82.92 (market cap $47.61B). The key difference: Becton Dickinson and Co and Block Inc are close in size by market cap, and Becton Dickinson and Co pays a 2.79% dividend while Block Inc pays none. Which is the better fit depends on your goals.
| BDX | XYZ | |
|---|---|---|
Market Cap | $41.51B | $47.61B |
Sector | Health | Technology |
52-Week High | $185.39 | $81.11 |
52-Week Low | $135.49 | $49.04 |
Enterprise Value | $57.97B | $42.48B |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
Block (XYZ) trades at $78.72, up 1.84% today, with a bullish technical outlook and strong analyst support (26 buy ratings). Recent earnings beat expectations in Q1 2026, though net income margin narrowed to 3.3% in 2025. The company faces a $45 million settlement over Cash App fraud allegations but continues to invest in AI and Square growth.
The stock offers upside to the $88.53 consensus target, driven by earnings momentum and AI initiatives, but risks include regulatory scrutiny, rising credit losses, and volatile cash flow. Investors should weigh solid long-term growth prospects against near-term execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Block Inc
Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →
